Pesquisas alternativas:
complex tear » complex tears (Expandir a Pesquisa), complex than (Expandir a Pesquisa), complex trait (Expandir a Pesquisa)
carlos rojek » carlos nojek (Expandir a Pesquisa), carlos rojas (Expandir a Pesquisa), carlos roger (Expandir a Pesquisa)
ift complex » cst complex (Expandir a Pesquisa), joint complex (Expandir a Pesquisa), giant complex (Expandir a Pesquisa)
nino carlos » cano carlos (Expandir a Pesquisa), bacino carlos (Expandir a Pesquisa), semino carlos (Expandir a Pesquisa)
nacl nino » nacl nano (Expandir a Pesquisa), nacl kno (Expandir a Pesquisa), nacl mno (Expandir a Pesquisa)
l cooper » _ cooper (Expandir a Pesquisa), m cooper (Expandir a Pesquisa), a cooper (Expandir a Pesquisa)
7.5 nacl » 3.5 nacl (Expandir a Pesquisa), 0.9 nacl (Expandir a Pesquisa)
james n » james a (Expandir a Pesquisa), james _ (Expandir a Pesquisa)
a ift » a dft (Expandir a Pesquisa), _ ift (Expandir a Pesquisa), a ft (Expandir a Pesquisa)
complex tear » complex tears (Expandir a Pesquisa), complex than (Expandir a Pesquisa), complex trait (Expandir a Pesquisa)
carlos rojek » carlos nojek (Expandir a Pesquisa), carlos rojas (Expandir a Pesquisa), carlos roger (Expandir a Pesquisa)
ift complex » cst complex (Expandir a Pesquisa), joint complex (Expandir a Pesquisa), giant complex (Expandir a Pesquisa)
nino carlos » cano carlos (Expandir a Pesquisa), bacino carlos (Expandir a Pesquisa), semino carlos (Expandir a Pesquisa)
nacl nino » nacl nano (Expandir a Pesquisa), nacl kno (Expandir a Pesquisa), nacl mno (Expandir a Pesquisa)
l cooper » _ cooper (Expandir a Pesquisa), m cooper (Expandir a Pesquisa), a cooper (Expandir a Pesquisa)
7.5 nacl » 3.5 nacl (Expandir a Pesquisa), 0.9 nacl (Expandir a Pesquisa)
james n » james a (Expandir a Pesquisa), james _ (Expandir a Pesquisa)
a ift » a dft (Expandir a Pesquisa), _ ift (Expandir a Pesquisa), a ft (Expandir a Pesquisa)
1
“... an underlying bleeding disorder in a patient with PPH, with disseminated intravascular coagulation (88%, n=23/26...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Lovelace, Leslie L., Cooper, Christopher L., Sodetz, James M., Lebioda, Lukasz
Publicado em 2011
“...-like “membrane attack complex” (MAC) of complement. The MAC consists of one C5b, C6, C7, and C8 and 12...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por James, D, Adams, R D, Spears, R, Cooper, G, Lupton, D J, Thompson, J P, Thomas, S H L
Publicado em 2010
“...% to 18%), peripheral vasoconstriction (n=10, 8%, 95% CI 4% to 14%) and headache (n=7, 5%, 95% CI 2% to 11...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Collart, Clara, Owens, Nick D. L., Bhaw-Rosun, Leena, Cooper, Brook, De Domenico, Elena, Patrushev, Ilya, Sesay, Abdul K., Smith, James N., Smith, James C., Gilchrist, Michael J.
Publicado em 2014
“..., as well as an increase in cell cycle length and a loss of synchronous cell divisions. Little is known...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Ward, Kim L., Hillman, David R., James, Alan, Bremner, Alexandra P., Simpson, Laila, Cooper, Matthew N., Palmer, Lyle J., Fedson, Annette C., Mukherjee, Sutapa
Publicado em 2013
“... Study at a tertiary hospital-based sleep clinic. Participants were patients (N = 2,673) referred...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Cooper, Gregory M., Durham, Emily L., Cray, James J., Siegel, Michael I., Losee, Joseph E., Mooney, Mark P.
Publicado em 2012
“... in vitro and in vivo. METHODS: Cells were derived from the dura mater from wild-type rabbits (WT; n=23...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Ng, David, Johnston, Jennifer J., Teer, Jamie K., Singh, Larry N., Peller, Lindsey C., Wynter, Jamila S., Lewis, Katie L., Cooper, David N., Stenson, Peter D., Mullikin, James C., Biesecker, Leslie G.
Publicado em 2013
“... research and in the clinic. Genome and exome sequencing can identify the genetic cause of a disease...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Cooper, Jennifer N., Columbus, Mindy L., Shields, Kelly J., Asubonteng, Julius, Meyer, Michelle L., Sutton-Tyrrell, Kim, Goodpaster, Bret H., DeLany, James P., Jakicic, John M., Barinas-Mitchell, Emma
Publicado em 2012
“... (−0.008 mm, P=0.16), individuals who lost at least 5% of their body weight experienced a significant mean...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Ward, Kim L., McArdle, Nigel, James, Alan, Bremner, Alexandra P., Simpson, Laila, Cooper, Matthew N., Palmer, Lyle J., Fedson, Annette C., Mukherjee, Sutapa, Hillman, David R.
Publicado no J Clin Sleep Med (2015)
“...: Ward KL, McArdle N, James A, Bremner AP, Simpson L, Cooper MN, Palmer LJ, Fedson AC, Mukherjee...”Publicado no J Clin Sleep Med (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Cooper, Arthur J. L., Sheu, K.-F. Rex, Burke, James R., Onodera, Osamu, Strittmatter, Warren J., Roses, Allen D., Blass, John P.
Publicado em 1997
“... in the presence of glutathione S-transferase constructs containing a Q(n) domain of pathological length (n = 62...”Publicado em 1997
Obter o texto integral
Obter o texto integral
Artigo
11
Por Cooper, Arthur J. L., Sheu, K-F. Rex, Burke, James R., Onodera, Osamu, Strittmatter, Warren J., Roses, Allen D., Blass, John P.
Publicado em 1998
“... give rise to extended stretches of polyglutamines (Q(n)) in the proteins expressed by the affected...”Publicado em 1998
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Bodnar, Lisa M., Catov, Janet M., Zmuda, Joseph M., Cooper, Margaret E., Parrott, Meredith S., Roberts, James M., Marazita, Mary L., Simhan, Hyagriv N.
Publicado em 2010
“... with serum 25(OH)D 37.5–75 nmol/L, SGA odds ratios (95% CI) for levels <37.5 and >75 nmol/L were 7.5 (1.8...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Kang, Soosung, Cooper, Garry, Fernandez Dunne, Sara, Luan, Chi-Hao, Surmeier, D. James, Silverman, Richard B.
Publicado no J Med Chem (2013)
“...Ca(V)1.3 L-type calcium channels (LTCCs) have been a potential target for Parkinson’s disease since...”Publicado no J Med Chem (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Karolemeas, Katerina, de la Rua-Domenech, Ricardo, Cooper, Roderick, Goodchild, Anthony V., Clifton-Hadley, Richard S., Conlan, Andrew J. K., Mitchell, Andrew P., Hewinson, R. Glyn, Donnelly, Christl A., Wood, James L. N., McKinley, Trevelyan J.
Publicado em 2012
“... in GB as a last-resort control measure to resolve intractable bTB herd breakdowns. These provide...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Bragge, Peter, Synnot, Anneliese, Maas, Andrew I., Menon, David K., Cooper, D. James, Rosenfeld, Jeffrey V., Gruen, Russell L.
Publicado no J Neurotrauma (2016)
“...Moderate-to-severe traumatic brain injury (TBI) remains a major global challenge, with rising...”Publicado no J Neurotrauma (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Haller, Steven T., Kalra, Philip A., Ritchie, James P., Chrysochou, Tina, Brewster, Pamela, He, Wencan, Yu, Haifeng, Shapiro, Joseph I., Cooper, Christopher J.
Publicado em 2013
“... (survivors, 7.3 ± 0.9 pg/ml, n=48 vs. non-survivors, 6.7 ± 1.0 pg/ml, n=12, p=0.06). The CD40/soluble CD40...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Halai, Reena, Bellows-Peterson, Meghan L, Branchett, Will, Smadbeck, James, Kieslich, Chris A, Croker, Daniel E, Cooper, Matthew A, Morikis, Dimitrios, Woodruff, Trent M, Floudas, Christodoulos A, Monk, Peter N
Publicado no Eur J Pharmacol (2014)
“... and directed in response to invading pathogens or tissue injury. Complement C3a and C5a are key mediators...”Publicado no Eur J Pharmacol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Hughes, Lorie L., Wang, Molin, Page, David L., Gray, Robert, Solin, Lawrence J., Davidson, Nancy E., Lowen, Mary Ann, Ingle, James N., Recht, Abram, Wood, William C.
Publicado em 2009
“... mammograms were eligible for a prospective trial conducted from 1997 to 2002 by the Eastern Cooperative...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por McArthur, Grant A., Foley, Kevin P., Fero, Matthew L., Walkley, Carl R., Deans, Andrew J., Roberts, James M., Eisenman, Robert N.
Publicado em 2002
“... kinase inhibitor p27(KIP1). Generation of Mad1/p27(KIP1) double-null mice revealed a number of synthetic...”Publicado em 2002
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Hadler, James L., Danila, Richard N., Cieslak, Paul R., Meek, James I., Schaffner, William, Smith, Kirk E., Cartter, Matthew L., Harrison, Lee H., Vugia, Duc J., Lynfield, Ruth
Publicado no Emerg Infect Dis (2015)
“...The Emerging Infections Program (EIP) is a collaboration between the Centers for Disease Control...”Publicado no Emerg Infect Dis (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo